Robin Feldman
-
- Intellectual Property and Patents 35
- Health Informatics top 10%
- Economics and Econometrics top 5%
- Pharmaceutical Economics and Policy 29
- Health Systems, Economic Evaluations, Quality of Life 9
- Innovation Policy and R&D 7
- Pharmacology top 10%
- Pharmaceutical industry and healthcare 15
-
- Biomedical Ethics and Regulation 15
-
- Law, AI, and Intellectual Property 14
-
- Private Equity and Venture Capital 9
- Co-authors
- Mark A. LemleyJohn C. NewmanConnie W. WangTom A. EwingW. Nicholson PriceMark J. RatainGarth W. StrohbehnDaniel A. Goldstein
- Journals
- Journal of Law and the Biosciences (4 papers)Hastings law journal (2 papers)Nature Biotechnology (2 papers)
- Partner nations
- United StatesSwedenIsrael
In The Last Decade
Robin Feldman
86 papers receiving 439 citations
Peers
Comparison fields: 5 of 104
- Management of Technology and Innovation 173
- Health Informatics 14
- Economics and Econometrics 239
- Pharmacology 45
- Business and International Management 8
Countries citing papers authored by Robin Feldman
This map shows the geographic impact of Robin Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Feldman more than expected).
Fields of papers citing papers by Robin Feldman
This network shows the impact of papers produced by Robin Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Feldman. The network helps show where Robin Feldman may publish in the future.
Co-authorship network
The 16 scholars most cited alongside Robin Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 9 | |
| 5 | Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation | 2019 | 4 |
| 6 | Artificial Intelligence in the Health care Space: How We Can Trust What We Cannot Know | 2019 | 20 |
| 7 | EMPIRICAL EVIDENCE OF DRUG PRICING GAMES—A CITIZEN’S PATHWAY GONE ASTRAY | 2017 | 3 |
| 8 | The Gender Gap in Startup Catalyst Organizations: Bridging the Divide between Narrative and Reality | 2017 | 1 |
| 9 | 2016 | 0 | |
| 10 | 2016 | 1 | |
| 11 | Database from Empirical Evidence of Drug Pricing Games - A Citizen's Pathway Gone Astray | 2016 | 1 |
| 12 | Drug Wars--A New Generation of Generic Pharmaceutical Delay | 2016 | 3 |
| 13 | Coming of Age for the Federal Circuit | 2014 | 2 |
| 14 | A Neurological Foundation for Freedom | 2012 | 8 |
| 15 | Understanding and Incentivizing Biosimilars | 2012 | 9 |
| 16 | The Role of the Subconscious in Intellectual Property Law | 2009 | 1 |
| 17 | Law's Misguided Love Affair with Science | 2008 | 4 |
| 18 | The Insufficiency of Antitrust Analysis for Patent Misuse | 2003 | 4 |
| 19 | Defensive Leveraging in Antitrust | 1999 | 1 |
| 20 | The economic feasibility of pharmacy patient medication profiles. | 1978 | 2 |
About Robin Feldman
Robin Feldman is a scholar working on Management of Technology and Innovation, Pharmacology and Economics and Econometrics, having authored 92 papers that have together received 479 indexed citations. Recurring topics across this work include Intellectual Property and Patents (35 papers), Pharmaceutical Economics and Policy (29 papers), Biomedical Ethics and Regulation (15 papers), Pharmaceutical industry and healthcare (15 papers), Law, AI, and Intellectual Property (14 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Private Equity and Venture Capital (9 papers) and Innovation Policy and R&D (7 papers). The work is most often cited by research in Management of Technology and Innovation (173 citations), Health Informatics (14 citations) and Economics and Econometrics (239 citations). Robin Feldman has collaborated with scholars based in United States, Sweden and Israel. Frequent co-authors include Mark A. Lemley, John C. Newman, Connie W. Wang, Tom A. Ewing, W. Nicholson Price, Mark J. Ratain, Garth W. Strohbehn, Daniel A. Goldstein, Alec Kacew and David A. Hyman. Their work appears in journals such as Journal of Law and the Biosciences, Hastings law journal, Nature Biotechnology, New England Journal of Medicine and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.